Santana T, Matuck B, Tenório JR, Braga MM. Can immunohistochemical biomarkers distinguish epithelial dysplasia degrees in actinic cheilitis? A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25 (1):e106-16.
doi:10.4317/medoral.23223
http://dx.doi.org/doi:10.4317/medoral.23223
1.
de Visscher JG, van der Wall I. Etiology of cancer of the lip. A
review. Int J Oral Maxillofac Surg.
1998;27:199-203. |
|
|||
|
||||
2.
Jadotte YT, Schwartz RA. Solar cheilosis: An ominous precursor
Part I. Diagnostic insights. J Am Acad Dermatol.
2012;66:173-84. |
|
|||
|
||||
3.
Jadotte YT, Schwartz RA. Solar cheilosis: An ominous precursor
Part II. Therapeutic perspectives. J Am Acad Dermatol.
2012;66:187-98. |
|
|||
|
||||
4. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press;2005. |
|
|||
|
||||
5.
Câmara PR, Dutra SN, Takahama Junior A, Fontes KBFC, Azevedo RS.
A comparative study using WHO and binary oral epithelial dysplasia
grading systems in actinic cheilitis. Oral Dis.
2016;22:523-9. |
|
|||
|
||||
6.
Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P.
Evaluation of a new binary system of grading oral epithelial
dysplasia for prediction of malignant transformation. Oral Oncol.
2006;42:987-93. |
|
|||
|
||||
7.
Smith J, Rattay T, Mcconkey C, Helliwell T, Mehanna H. Biomarkers
in dysplasia of the oral cavity : A systematic review. Oral
Oncol.
2009;45:647-53. |
|
|||
|
||||
8.
Dekkers O, Egger M, Altman D, Vandenbroucke J. Distinguishing case
series from cohort studies. Ann Intern Med.
2012;156:37-40. |
|
|||
|
||||
9.
Ariotti C, Wagner VP, Salvadori G, Carrard VC, Martins MAT, Filho
JJ da C, et al. VEGFR1 and VEGFR2 in lip carcinogenesis and its
association with microvessel density. Tumor Biol.
2015;36:7285-92. |
|
|||
|
||||
10.
Garcia NG, Oliveira DT, Pereira Lauris JR, Custodio Domingues MA,
Minicucci EM, Soares CT. Loss of cytokeratin 10 indicates
malignant transformation in actinic cheilitis. Clin Oral Investig.
2016;20:745-52. |
|
|||
|
||||
11.
Garcia NG, Gonzalez-Moles MA, Ruiz-Avila I, Bravo M, Ramos-Garcia
P, Minicucci EM, et al. Asymmetrical proliferative pattern loss
linked to cyclin D1 overexpression during malignant transformation
of the lip epithelium. J Eur Acad Dermatol Venereol.
2016;30:1315-20. |
|
|||
|
||||
12.
Bianco BC, Scotti FM, Vieira DSC, Biz MT, Castro RG, Modolo F.
Immunohistochemical expression of matrix metalloproteinase-1,
matrix metalloproteinase-2 and matrix metalloproteinase-9,
myofibroblasts and Ki-67 in actinic cheilitis and lip squamous
cell carcinoma. Int J Exp Pathol.
2015;96:311-8. |
|
|||
|
||||
13.
Chrun E da S, Modolo F, Vieira DSC, Borges ALSJ, Castro RG, Daniel
FI. Immunoexpression of HDAC1, HDAC2 and HAT1 in actinic cheilitis
and lip squamous cell carcinoma. Oral Dis.
2016;38:42-9. |
|
|||
|
||||
14.
Barbosa NG, Souza LB, Nonaka CFW, Silveira EJD. Evaluation of
hypoxia, angiogenesis, and lymphangiogenesis in actinic cheilitis.
Int J Dermatol.
2016;55:E573-8. |
|
|||
|
||||
15.
Gonçalves AS, Oliveira JP, Oliveira CFP, Silva TA, Mendonça EF,
Wastowski IJ, et al. Relevance of HLA-G, HLA-E and IL-10
expression in lip carcinogenesis. Hum Immunol.
2016;77:785-90. |
|
|||
|
||||
16.
Lopes MLD de S, de Oliveira DHIP, Sarmento DJ de S, Queiroz LMG,
Miguel MC da C, da Silveira ÉJD. Correlation between cell cycle
proteins and hMSH2 in actinic cheilitis and lip cancer. Arch
Dermatol Res.
2016;308:165-71. |
|
|||
|
||||
17.
Ariotti C, Wagner VP, Salvadori G, Carrard VC, Trevizani Martins
MA, da Cunha Filho JJ, et al. VEGFR1 and VEGFR2 in lip
carcinogenesis and its association with microvessel density. Tumor
Biol.
2015;36:7285-92. |
|
|||
|
||||
18.
Araujo CP, Silva Gurgel CA, Goncalves Ramos EA, Freitas VS,
Barbosa Junior A de A, Pedreira Ramalho LM, et al. Accumulation of
CD1a-positive Langerhans cells and mast cells in actinic
cheilitis. J Mol Histol.
2010;41:357-65. |
|
|||
|
||||
19.
Lopes MLD de S, Nonaka CFW, Queiroz LMG, de Souza LB, Miguel MC da
C, da Silveira EJD. Pattern of galectins expression in actinic
cheilitis with different risks of malignant transformation. J Oral
Pathol Med.
2016;45:621-6. |
|
|||
|
||||
20.
Gomes JO, Carvalho M de V, Fonseca FP, Gondak RO, Lopes MA, Vargas
PA. CD1a+and CD83+Langerhans cells are reduced in lower lip
squamous cell carcinoma. J Oral Pathol Med.
2016;45:433-9. |
|
|||
|
||||
21.
De Oliveira DHIP, de Sousa Lopes MLD, de Santana Sarmento DJ,
Queiroz LMG, da Costa Miguel MC, da Silveira ÉJD. Relationship
between the epithelial expression of hMLH1, MDM2, and p63 and
lower lip carcinogenesis. J Oral Pathol Med.
2014;43:357-63. |
|
|||
|
||||
22.
Alves MGO, Delgado A da M, Balducci I, Carvalho YR, Rodrigues
Cavalcante AS, Almeida JD. Study of MDM2 and SUMO-1 expression in
actinic cheilitis and lip cancer. Arch Dermatol Res.
2014;306:837-41. |
|
|||
|
||||
23.
Salvadori G, dos Santos JN, Trevizani Martins MA, Vasconcelos AC,
Meurer L, Rados PV, et al. Ki-67, TGF-beta 1, and elastin content
are significantly altered in lip carcinogenesis. Tumor Biol.
2014;35:7635-44. |
|
|||
|
||||
24.
Sarmento DJ de S, de Almeida WL, Miguel MC da C, Queiroz LMG,
Godoy GP, Da Cruz MCFN, et al. Immunohistochemical analysis of
mismatch proteins in carcinogenesis of the lower lip.
Histopathology.
2013;63:371-7. |
|
|||
|
||||
25.
Araújo CP, De Aquino Xavier FC, Silva Gurgel CA, Gonçalves Ramos
EA, Souza Freitas V, Schlaepfer-Sales CB, et al. Elastin
accumulation in actinic cheilitis with different degrees of
epithelial dysplasia. Int J Morphol.
2012;30:627-33. |
|
|||
|
||||
26.
von Bubnoff D, Zahn S, Wenzel J, Wilms H, Bieber T, Lüftl M.
Indoleamine 2,3-dioxygenase expression in early keratocyte
neoplasia of the lower lip correlates to the degree of cell
atypia. Pathol Int.
2012;62:105-11. |
|
|||
|
||||
27.
Souza LR, Fonseca-Silva T, Pereira CS, Santos EP, Lima LC,
Carvalho H a., et al. Immunohistochemical analysis of p53, APE1,
hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous
cell carcinoma. Histopathology.
2011;58:352-60. |
|
|||
|
||||
28.
Freitas VS, de Andrade Santos PP, Freitas R de A, Pinto LP, de
Souza LB. Mast cells and matrix metalloproteinase 9 expression in
actinic cheilitis and lip squamous cell carcinoma. Oral Surg Oral
Med Oral Pathol Oral Radiol Endodont.
2011;112:342-8. |
|
|||
|
||||
29.
Chou A, Dekker N, Jordan RCK. Identification of novel fibroblast
growth factor receptor 3 gene mutations in actinic cheilitis and
squamous cell carcinoma of the lip. Oral Surg Oral Med Oral Pathol
Oral Radiol Endodont.
2009;107:535-41. |
|
|||
|
||||
30. Costa NL, Oton-Leite AF, Cheim-Júnior AP, Alencar Rde C, Bittar GO, Silva TA, et al. Density and migration of mast cells in lip squamous cell carcinoma and actinic cheilitis. Histol Histopathol. 2009;24:457-65. |
|
|||
|
||||
31.
Fontes A, de Sousa SM, dos Santos E, Martins MT. The severity of
epithelial dysplasia is associated with loss of maspin expression
in actinic cheilitis. J Cutan Pathol.
2009;36:1151-6. |
|
|||
|
||||
32.
Aquino Xavier FC, Rodini CO, Pedreira Ramalho LM, Mantesso A,
Nunes FD. WNT-5A, but not matrix metalloproteinase 3 or
beta-catenin protein, expression is related to early stages of lip
carcinogenesis. J Oral Pathol Med.
2009;38:708-15. |
|
|||
|
||||
33.
Aquino Xavier FC, Takiya CM, Almeida Reis SR, Pedreira Ramalho LM.
p63 Immunoexpression in lip carcinogenesis. J Mol Histol.
2009;40:131-7. |
|
|||
|
||||
34.
de Freitas Mda C, Ramalho LM, Xavier FC, Moreira AL, Reis SR. p53
and MDM2 protein expression in actinic cheilitis. J Appl Oral Sci.
2008;16:414-9. |
|
|||
|
||||
35.
Cury PR, Furuse C, de Araujo NS, de Araujo VC. Signal transducer
and activator of transcription-3 expression and activation is
dysregulated in actinic cheilitis. J Cutan Pathol.
2007;34:606-11. |
|
|||
|
||||
36. Pontes HAR, Aguiar MCF de, Mesquita RA, Pontes FSC, Silveira Junior JB da. Imunoexpressão da proteína de reparo hMSH2 em queilite actínica e mucosa labial normal. Rev Bras Cancerol. 2005;51:23-30. |
|
|||
|
||||
37.
Brennan M, Migliorati CA, Lockhart PB, Wray D, Rcps FDS, Rcsed
FDS, et al. Management of oral epithelial dysplasia : a review.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2007;103:e1-e12. |
|
|||
|
||||
38.
Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and
the development of invasive squamous cell carcinoma. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod.
1995;79:321-9. |
|
|||
|
||||
39.
Pilati SFM, Bianco BC, Vieira DSC, Modolo F. Histopathologic
features in actinic cheilitis by the comparison of grading
dysplasia systems. Oral Dis.
2017;23:219-24. |
|
|||
|
||||
40.
Peng, R. The reproducibility crisis in science: A statistical
counterattack. Significance.
2015;12:30-2. |
|
|||
|
||||
41.
Ferreira AM, de Souza Lucena EE, de Oliveira TC, da Silveira EJD,
de Oliveira PT, de Lima KC. Prevalence and factors associated with
oral potentially malignant disorders in Brazil's rural workers.
Oral Dis.
2016;22:536-42. |
|